Revvity Retained Earnings (Accumulated Deficit) 2010-2024 | RVTY

Revvity retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Revvity retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $5.759B, a 3.97% increase year-over-year.
  • Revvity retained earnings (accumulated deficit) for 2023 were $5.609B, a 13.29% increase from 2022.
  • Revvity retained earnings (accumulated deficit) for 2022 were $4.951B, a 12.09% increase from 2021.
  • Revvity retained earnings (accumulated deficit) for 2021 were $4.417B, a 25.94% increase from 2020.
Revvity Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $5,609
2022 $4,951
2021 $4,417
2020 $3,507
2019 $2,812
2018 $2,602
2017 $2,381
2016 $2,119
2015 $1,991
2014 $1,811
2013 $1,684
2012 $1,549
2011 $1,511
2010 $1,535
2009 $1,289
Revvity Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $5,759
2024-06-30 $5,673
2024-03-31 $5,627
2023-12-31 $5,609
2023-09-30 $5,539
2023-06-30 $5,539
2023-03-31 $5,512
2022-12-31 $4,951
2022-09-30 $4,834
2022-06-30 $4,757
2022-03-31 $4,585
2021-12-31 $4,417
2021-09-30 $4,236
2021-06-30 $4,117
2021-03-31 $3,879
2020-12-31 $3,507
2020-09-30 $3,135
2020-06-30 $2,966
2020-03-31 $2,837
2019-12-31 $2,812
2019-09-30 $2,755
2019-06-30 $2,704
2019-03-31 $2,643
2018-12-31 $2,602
2018-09-30 $2,532
2018-06-30 $2,463
2018-03-31 $2,407
2017-12-31 $2,381
2017-09-30 $2,429
2017-06-30 $2,346
2017-03-31 $2,150
2016-12-31 $2,119
2016-09-30 $2,061
2016-06-30 $2,011
2016-03-31 $1,955
2015-12-31 $1,991
2015-09-30 $1,931
2015-06-30 $1,884
2015-03-31 $1,843
2014-12-31 $1,811
2014-09-30 $1,788
2014-06-30 $1,753
2014-03-31 $1,711
2013-12-31 $1,684
2013-09-30 $1,625
2013-06-30 $1,593
2013-03-31 $1,573
2012-12-31 $1,549
2012-09-30 $1,572
2012-06-30 $1,551
2012-03-31 $1,525
2011-12-31 $1,511
2011-09-30 $1,703
2011-06-30 $1,676
2011-03-31 $1,655
2010-12-31 $1,535
2010-09-30 $1,359
2010-06-30 $1,354
2010-03-31 $1,305
2009-12-31 $1,289
2009-09-30 $1,257
2009-06-30 $1,251
2009-03-31 $1,238
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00